In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar

Annals of Clinical Microbiology and Antimicrobials

Volumn 3, Issue , 2004, Pages

  Bansal, Devendra ^a   Sehgal, Rakesh ^a   Chawla, Yogesh ^a   Mahajan, Ramesh Chander ^a   Malla, Nancy ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIAMEBIC AGENT; CHLOROQUINE; EMETINE; METRONIDAZOLE; NITROBLUE TETRAZOLIUM; TINIDAZOLE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; DRUG ACTIVITY; DRUG SENSITIVITY; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; GENETIC STRAIN; IC 50; IN VITRO STUDY; INDIA; ISOLATION PROCEDURE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; STRAIN DIFFERENCE;

EID: 33750492287     PISSN: 14760711     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-3-27     Document Type: Article

References (19)

1. Walsh JA: Problems in recognition and diagnosis of amoebiasis: estimation of the global magnitude of mortality and morbidity. Rev Infect Dis 1986, 8:228-38.
2. Diamond LS, Clark CG: A redescription of Entamoeba histolytica Schaudinn 1903 (emended walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol 1993, 40:340-4.
3. Martinez-Palomo A, Martinez-Baez M: Selective primary health care: strategies for control of disease in the developing world X amoebiasis. Rev Infect Dis 1983, 5:1093-1102.
4. Gomez MD, Perez DG, Ayala P, Samuelson J, Orozco E: Physiology and molecular biology of multidrug resistance in Entamoeba histolytica. Arch Med Res 1996, 27:421-25.
5. Pittman FE, Pittman JC: Amoebic liver abscess following metronidazole therapy for amoebic colitis. Am J Trop Med Hyg 1974, 23:146-50.
6. Burthard GD, Mirelman D: Entamoeba histolytica virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes. Exp Parasitol 1988, 66:231-42.
7. Upcroft P, Upcroft JA: Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 2001, 14:150-64.
8. Aguirre-Cruz ML, Valadez-Salazar A, Munoz O: In vitro sensitivity of Entamoeba histolytica to metronidazole. Arch Invest Med (Mex) 1990, 21:23-6.
9. Adagu SI, Noider D, Warhurst DC, Rossignol JF: In vitro activity of nitazoxanide and related compounds against isolates of Glardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis. J Antimicrob Chemother 2002, 49:103-11.
10. Bansal D, Sehgal R, Chawla Y, Mahajan RC, Malla N: Comparative Evaluation of Hexokinase Isoenzyme Typing and Antigen Detection for Differentiation of Entamoeba histolytica and Entamoeba dispar. Nepal Med Coll J in press.
11. Center disease Control Bulletin United States Public Health Service Publication (USPHS); 1948.
12. Robinson GL: The laboratory diagnosis of human parasite amoebae. Trans R Soc Trop Med Hyg 1968, 62:285-94.
13. Diamond LS, Harlow R, Cupnick CC: A new medium for axenic cultivation of Entamoeba histolytica. Trans R Soc Trop Med Hyg 1978, 72:431-32.
14. Upcroft JA, Upcroft P: Drug susceptibility testing of anaerobic protozoa. Antimicrob Agents Chemother 2001, 45:1810-14.
15. Mukhopadhyay RM, Chaudhuri SK: Rapid in vitro tests for determination of antiamebic activity. Trans R Soc Trop Med Hyg 1996, 90:189-91.
16. Ayala P, Samuelson J, Wirth D, Orozco E: Entamoeba histolytica: physiology of multidrug resistance. Exp Parasitol 1990, 71:169-75.
17. Voolmann T, Boreham P: Metronidazole resistant Trichomonas vaginalis in Brisbane. Med J Aust 1993, 159:490.
18. Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA: Treatment of patients with refractory giardiasis. Clin Infect Dis 2001, 33:22-8.
19. Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PC, Murray HW: Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2000, 31:1104-7.